Environment Targets & Initiatives

Medium-Term Environmental Action Plan 21-25

Mitsubishi Tanabe Pharma Group views environmental measures as an important management issue and has identified “environment-friendly business” as a materiality that contributes to the SDGs, and has formulated the Medium-Term Environmental Action Plan 21-25, which established six environmental themes, including monitoring indicators, as priority items.

Raising GHG Emission Volume Reduction Targets

The Group has raised its greenhouse gas (GHG) emissions volume reduction targets for the Medium-Term Environmental Action Plan 21-25 based on the significant reductions anticipated in GHG emissions volumes through action plans intended to achieve this under an action plan to reduce these emissions that was decided on in-house for fiscal 2023.

GHG emission volume (Global: Scope 1 + 2)

FY2025 target: 25% -> 58% reduction compared to FY2019
FY2030 target: 45% -> 69% reduction compared to FY2019

State of Medium-Term Environmental Action Plan 21-25 Achievement

	Targets	Principal Initiatives and Results in Fiscal 2023	Environmental SDGs
Energy conservation and global warming mitigation	Reduce GHG emissions by 58% by fiscal 2025 compared to fiscal 2019 (Global: Scope 1 + 2)	29% reduction compared to fiscal 2019	Goal 7 Goal 13
	Promote reduction of supply chain CO₂ emissions	Scope 3 was tracked and disclosed in the Sustainability Report
	Appropriately manage fluorocarbons	Amount leaked 43 kg (74 t-CO₂eq)
Reduction of waste, recycling and reuse of resources	Reduce amount of waste generated by 30% by 2025 compared to fiscal 2019 (domestic) Reduce amount of final waste disposed by 50% by 2025 compared to fiscal 2019 (domestic)	Compared to fiscal 2019 40% reduction of waste generated in Japan 71% reduction in final waste disposal	Goal 12
Reduction of waste, recycling and reuse of resources	Promote reduction of plastic usage and recycling of waste	Plastic waste emissions in Japan 181 tons *Emission volume is the total for the Group 35% recycling rate	Goal 12
Effective use of water resources	Reduce water usage volume by 15% by 2025 compared to fiscal 2019 (Global)	38% reduction compared to fiscal 2019	Goal 6
Prevention of environmental pollution	Continue to maintain COD emissions at current levels compared to fiscal 2019 (Domestic)	13% reduction compared to fiscal 2019	Goal 6 Goal 12
Prevention of environmental pollution	Reduce PRTR emission substances (Domestic)	60% reduction compared to fiscal 2019	Goal 6 Goal 12
Preservation of biodiversity	Promote understanding and reduce environmental impact on biodiversity Promote biodiversity preservation efforts	Awareness of environmental impact through monitoring, etc., and measures to reduce impact Participation in activities to preserve the natural environment, such as tree-planting on Mt. Ikoma in Osaka Prefecture, and preservation of rural landscapes in the Hachioji-Takiyama area of Tokyo	Goal 15
Enhancement of environmental management	Strengthen environmental risk management, promote compliance, and prevent environmental accidents	Performance of environmental audits Performance of environmental education and training Appropriate response to environmental trouble and revisions to environmental laws and regulations
Enhancement of environmental management	Maintain zero environmental accidents and violations of laws and regulations	While maintaining zero environmental accidents and violations of laws and regulations for seven years

Material Balance

The figures below show the amount of resources (inputs) directly consumed and the environmental impact (outputs) discharged by our business activities in fiscal 2023.

*Excluding PRTR subtances

Calculation Standards for Environmental Performance Indicators
［PDF：168KB］

Participation in Initiatives and Industry Group Activities

The Group participates in the following initiatives and industry group activities to solve social issues related to the environment and continues to be a company that is trusted by society.

Activities of Japan Climate Initiative (JCI)*

In an effort to achieve the decarbonized society required in the Paris Agreement, the Company has participated in the Japan Climate Initiative* since 2021. Additionally, JCI has been sending regular messages to encourage the Japanese Government to achieve the target of limiting global temperature increase to the 1.5°C set out in the Paris Accords, and in fiscal 2023, we expressed our support for the “Overcoming Two Crises with Renewable Energy and Carbon Pricing” message.

*The Japan Climate Initiative (JCI) is a network comprised of various entities (non-government actors) besides the national government that includes companies, municipalities, and NGOs, aiming to achieve a carbon-free society. Companies that are actively working on climate change measures are joining in support of the JCI Declaration which states, “Joining the front line of global trend for decarbonization from Japan.”

Activities of Pharmaceutical Industry Associations

The Company participates as a member of the Environmental Committee of The Federation of Pharmaceutical Manufacturers’ Associations of Japan and contributes to formulating guidelines and action plans for the industry. We also participate in the Carbon Neutral Working Group and are working to achieve the carbon dioxide emissions reduction target based on Japan Business Federation’s (Keidanren’s) requests. Furthermore, we are participating in an environmental issues study group established by the Japan Pharmaceutical Manufacturers Association (JPMA) in fiscal 2022, and are working to address environmental issues as a pharmaceutical industry.